Minnesota Law Limiting Pharmaceutical Company Gifts To Physicians Could Lead To Similar Laws In Other States
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Primary Care / General Practice
Article Date: 15 Oct 2007 - 10:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
A Minnesota law that limits gifts from pharmaceutical companies could lead to similar laws in other states, the New York Times reports. Under the law, Minnesota since 2005 has limited gifts from pharmaceutical companies to physicians to a value of $50 annually, and the "effect on drug makers has been profound," the Times reports. In the year after the limit took effect, the number of visits by pharmaceutical company sales representatives reported by primary care physicians in Minnesota decreased at about twice the rate reported by physicians nationwide, according to ImpactRx.
No other states have implemented similar limits, but New Jersey Attorney General Anne Milgram (D) in September announced the formation of a task force that will examine proposals to limit gifts from pharmaceutical companies to physicians and said she plans to examine the Minnesota limit. According to the Times, the "interest in legislation to register or limit the food, gifts and money that drug and device makers lavish on doctors stems from growing concerns that these benefits lead doctors to prescribe more, and more expensive, drugs and devices, raising the costs of health care and changing care to patients."
Milgram said, "When you see a doctor, you should have confidence that the advice you get is based on what's best for you and not on some financial incentives or gifts that the doctor is getting." However, Leslie Pott, a spokesperson for AstraZeneca, said, "We believe it is important that physicians have access to the latest information on our drugs," and, "given a physician's demanding clinical schedule, the most efficient time for doctors and medical staff to meet with representatives is often during lunch hour" (Harris, New York Times, 10/12).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/85470.php>
APA
http://www.medicalnewstoday.com/releases/85470.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



